Nuplazid Email: “Helping you identify your symptoms” Mar 25, 2019Mar 27, 2019 Brand: Nuplazid (pimavanserin), Capsules Parent Company: Acadia Pharmaceuticals Drug Type: Boxed Warning Drug Category: Neurology Campaign: Post-Launch Targeting: Patients, Caregivers Patient Website: https://www.nuplazid.com/ HCP Website: https://www.nuplazidhcp.com Received: Mar 26, 2019 at 5:30 PM Subject: Helping you identify your symptoms From: ACADIA Pharmaceuticals Inc.